Pancreatobiliary Carcinoma — Trials

Pancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 700
Recruiting: 403
Ph III recruiting: 36
Growth YoY: +20.3%
Industry share: 30%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (303)

clinicaltrialsPublishedShowing 1,651–1,700 of 2,132 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00026104	Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer	completed	Phase 2	154	National Cancer Institute (NCI)NIH	1	Oct 30, 2020	clinicaltrials
NCT00114179	Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery	completed	Phase 2	82	National Cancer Institute (NCI)NIH	1	Oct 30, 2020